Search form

Veterinary support

1-866-683-0660

Newsroom

Read the full article here: Pet Meds (1.26 MB)
PORTLAND, Maine, March 15, 2016 /PRNewswire/ -- Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces today the signing of a definitive agreement to sell 100% of the company to DECHRA HOLDINGS US Inc., a... Read More
Read the full article here: A Big Thank You to Putney (118.77 KB)
Read the full article here: Victor Medical to Distribute Putney's Full Line (92.26 KB)
Read the full article here: Putney Supports Veterinarians with New Website Features (63.66 KB)
Portland, ME—December 15, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces today that Victor Medical Company will now distribute Putney’s entire line of FDA approved veterinary generic products... Read More

VIN

Read the full article here: Putney receives FDA approval for generic of Tresaderm® (83.8 KB)
Read the full article here: Women to Watch, Class of 2009: Where are they now? (213.48 KB)
Portland, ME - Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has received FDA approval for its Thiabendazole, Dexamethasone, Neomycin Sulfate Solution, the first and only generic of Tresaderm®. This is... Read More
Portland, ME—July 21, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Gary Eaton as Vice President of Sales and Marketing, reporting to Jean Hoffman, Putney’s President and CEO. As part of... Read More
Read the full article here: Putney releases another FDA approved generic (194.65 KB)
Portland, ME—June 17, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces today that its Tiletamine-Zolazepam (tiletamine... Read More

DVM

Read the full article here: Generic Enrofloxacin (161.13 KB)
Read the full article here: Putney continues approval spree with generic Zoetis drug (351.86 KB)
Portland, ME—April 6, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has received FDA Center for Veterinary Medicine (CVM) approval for its Tiletamine-Zolazepam (tiletamine HCl and zolazepam HCl)... Read More
Portland, ME—April 14, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has commercially launched its fifth veterinary generic drug in less than five months. Putney is introducing its Enrofloxacin... Read More
Read the full article here: Putney launches generic carprofen sterile injectable solution (98.33 KB)
Read the full article here: Putney Releases Injectable Carprofen for Dogs (206.93 KB)
Portland, ME—March 3, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has promoted Dr. Anthony Lucas, BVMS, PhD to the newly created position of Senior Vice President of Scientific and Medical Affairs.... Read More
Read the full article here: Drug Maker Putney Achieves Series of Regulatory Victories (300.06 KB)
  Portland, ME—March 10, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces results of its online survey of veterinarians, in which 100% of veterinarians completing the survey said they believe... Read More
Read the full article here: Putney Launches Carprofen Chewable Tablets (106.2 KB)
RACE-approved breakfast meeting presents new approaches to building pet owner loyalty Portland, ME—February 3, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on thedevelopment and sale of generic prescription medicines for pets, is sponsoringa continuing education course... Read More
Portland, ME—February 10, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announced today the commercial launch of its Carprofen Sterile Injectable Solution, Putney’s FDA approved generic of Rimadyl® ... Read More
Read the full article here: Putney Sponsors Free Continuing Education Course at WVC 2015 (92.94 KB)
RACE-approved breakfast meeting presents new approaches to managing the veterinary pharmacy Portland, ME—January 7, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, is sponsoring a continuing education... Read More
Read the full article here: Putney CEO... Read More
Putney Receives Fifth FDA Approval in Five Months Company expects new product launches to accelerate revenue growth in 2015 Portland, ME—January 13, 2015—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has... Read More
Read the full article here:  Putney Celebrates Regulatory Successes (205.28 KB)
Read the full article here: Putney Receives Fifth FDA Approval in Five Months (75.56 KB)
Read the full article here: Putney Launches Meloxicam Solution for Injection (78.07 KB)
Portland, ME—December 10, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Catherine Conaty as Vice President of Finance & Controller, reporting to Putney CFO, William McKee. Conaty joins Putney... Read More
Read the full article here: Putney Hires Catherine... Read More
Portland, ME—December 18, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces today that it is launching Putney... Read More
Read the full article here: Putney... Read More
Portland, ME—December 18, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announces today that it is launching ... Read More
Portland, ME—November 17, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has received FDA Center for Veterinary Medicine (CVM) approval for its Meloxicam Solution for Injection (generic to Metacam® Solution... Read More
Read the full article here: Putney Captures Enrofloxacin Flavored Tablet Market (80.1 KB)
Read the full article here: Pet Rock in the Park to benefit fight against canine cancer (80.35 KB)
Portland, ME—September 3, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, is sponsoring “Pet Rock in the Park”, a fundraiser for Chase Away K9 Cancer, a division of the National Canine Cancer Foundation. At... Read More
Read the full article here: Putney: Fighting for generic share in a competitive marketplace (470.79 KB)
Veterinarians now have unrestricted access to Putney’s generic to Baytril® Taste Tabs® Portland, ME—September 30, 2014—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched Enrofloxacin Flavored Tablets... Read More
Read the full article here: EY... Read More
Portland, ME—July 1, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, today announces the addition of Kelley Shimansky to its senior leadership team. As... Read More
Read the full article here: Putney... Read More
Portland, ME—June 2, 2014—Putney,  Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has strengthened its strategic sales capabilities with recent changes to its commercial team. In recognition of his strong... Read More
Portland, ME—June 12, 2014—Jean Hoffman, president and CEO of Putney, Inc., was named the New England Ernst ... Read More
Read the full article here: Rise of Generic Pet Medications (394.54 KB)
Read the full article here: ... Read More
Read the full article here: Putney hires Kevin Woods (58.55 KB)
Portland, ME—April 29, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Kevin Woods as Director of Supply Chain, responsible for ensuring reliable supply of Putney’s expanding portfolio of FDA-... Read More
Portland, ME—May 19, 2014—Jean Hoffman, president and CEO of Putney, Inc., has been named a finalist for the Ernst & Young (EY) Entrepreneur of the Year™ 2014 Award in the New England region. The awards program recognizes... Read More
Portland, ME—March 4, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Richard Davan as Director of Regulatory Affairs, as the company continues to expand its pipeline of FDA-approved veterinary... Read More
Portland, ME—March 11, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has expanded its sales team to meet the growing demand for its FDA-approved veterinary generics.  Kelvin Luther joins Putney as... Read More
Read the full article here: Lucky WVC Attendees to Win Generic Drugs from Putney (94.94 KB)
Read the full article here: Portland Company Makes Generic Pet Meds
Read the full article here: Putney CEO Jean Hoffman Finds Success in Generic Pet Meds (157.54 KB)
Portland, ME—February 10, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, will donate nearly $2000-worth of Putney products to prize draw winners at the Western Veterinary Conference (WVC). In addition... Read More
Portland, ME—February 17, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has moved its headquarters to accommodate its growing team and in anticipation of the company’s continued growth in the coming... Read More
Portland, ME—January 13, 2014—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, is sponsoring a continuing education course entitled “Are Veterinary Generic Drugs Equivalent to Brand-Name Drugs?” at the North... Read More
Read the full article here: Portland to honor businesses for boosting economic development (149.69 KB)
Portland, ME—February 11, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched generic veterinary Cefpodoxime Proxetil tablets. Putney’s veterinary Cefpodoxime Proxetil is the first and only generic... Read More
Putney Launches Third FDA-Approved Veterinary Generic in 2013CEO Jean Hoffman says R&D investment ‘pays off’ as products emerge from pipeline  Portland, ME—December 2, 2013—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription... Read More
Portland, ME—December 11, 2013—Putney, Inc., a rapidly growing veterinary pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has promoted Shannon Lancaster to Director of Financial Planning and Analysis, and Jason Dobrinick to Manager of Inside ... Read More
Portland, ME—December 18, 2013—Putney, Inc., a rapidly growing veterinary pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has been named Portland’s 2013 Business of the Year in recognition of the company’s contribution to Portland’s economic... Read More
Portland, ME—November 5, 2013—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Greg Radziszewski as Senior Director of Information Technology. Radziszewski has over twenty years in delivering and... Read More
Portland, ME—November 13, 2013—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, today announced it ranked number 290 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, life... Read More
Read the full article here: Outsourcing logistics can pay off big time (351.1 KB)
Portland, ME—October 15, 2013—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, was named the number one Best Place to Work in Maine for 2013. The program, a project of the Maine State Council of the Society... Read More
Read the full article here: Putney named to Inc. 5000 list for second time (139.96 KB)
Read the full article here: Putney adds video CE courses (92.65 KB)
Read the full article here: Putney names Ellen Tobias as VP of Technical Operations (93.17 KB)
Read the full article here: What makes Putney great (1.1 MB)
Read the full article here: Putney Named 10th Best Small Workplace in United States (430.32 KB)
Portland, ME—September 3, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched new features on its website that support two important company initiatives – educating veterinarians about the... Read More
Portland, ME—September 11, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has named Ellen Tobias as Vice President of Technical Operations, reporting to Putney’s CEO and President, Jean Hoffman. Tobias has... Read More
Portland, ME—September 17, 2013—Putney,Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, continues to expand its sales team... Read More
Portland, ME—September 23, 2013—Putney Inc., a rapidly growing pharmaceutical company... Read More
Read the full article here: Study: Creative work force growing in Portland (156.19 KB)
Read the full article here: Putney sponsors free neutering event in Portland (96.07 KB)
Putney Sponsors Free Neutering Event in Portland Portland, ME—August 5, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has teamed up. with Forest Avenue Veterinary Hospital (FAVH) and local restaurant,... Read More
Portland, ME—August 26, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has been named to the 2013 ... Read More
Portland, ME—July 31, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, welcomes summer intern Michael LaFond as part of the new Innovate for Maine internship program, supported by the Blackstone Charitable... Read More
Read the full article here: Putney Expands Inside Sales Team (97.22 KB)
Driven by demand for its FDA approved veterinary Cefpodoxime Proxetil, Enrofloxacin Flavored Tablets and Carprofen Caplets, Putney expands its inside sales team. The move makes its FDA approved veterinary generics available to all veterinarians—even when distributors are blocked from carrying... Read More
Portland, ME—May 13, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has promoted Jennifer Johansson to Senior Vice President of Regulatory Policy... Read More
Read the full article here: Putney Launches Generic of Baytril® Taste Tabs® (117.66 KB)
Putney’s President and CEO, Jean Hoffman, will deliver the keynote address at University of New England’s College of Pharmacy Awards and Honors Ceremony. Hoffman to highlight the importance of entrepreneurial spirit in achieving the American dream. Portland, ME—April 24, 2013— Jean Hoffman,... Read More
Second FDA approval in four months demonstrates Putney’s deep scientific capabilities Putney launches Enrofloxacin Flavored Tablets, the first and only available generic of Baytril® Taste Tabs®, the Company’s fourth FDA approved veterinary generic medicine. Jean Hoffman, president and CEO of... Read More
Read the full article here: Buying pet meds elsewhere (637.96 KB)
Portland, ME—March 4, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has hired Dr. Hongna Wang, PhD and Dr. Frank Femia, PhD as Senior Manager and Manager, respectively, of Product Development. Both Dr.... Read More
Putney’s new website provides veterinarians with resources to learn more about its veterinary generic products as well as a list of distributors who carry them. Portland, ME—March 26, 2013—Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic... Read More
Read the full article here: Putney expands Product Development Team (90.41 KB)
Read the full article here: Dr. Honga Wang and Dr. Frank Femia Join Putney, Inc. (238.48 KB)
Putney Reports Growing Interest in CVM-approved Veterinary Generics Company will repeat popular continuing education course at WVC 2013 Portland, ME—February 5, 2013— Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines... Read More
Read the full article here: Veterinary generics receive interest from NAVC attendees (106.04 KB)
Read the full article here: WVC launches: New veterinary products rolled out (108.32 KB)
Portland, ME—January 7, 2013—Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, is sponsoring a continuing education course entitled “Veterinary Generic Drugs: Good Medicine, Good Business” at the North American... Read More
Read the full article here: Jean Hoffman named one of thirteen newsmakers to watch in 2013 (606.62 KB)
Read the full article here: Best Places to Work in ME - Putney, Inc (777.03 KB)
Read the full article here: Founder of Veterinary Generic Medicine Company Recognized (441.96 KB)
Read the full article here: Putney Strengthens Quality Assurance Team (76.13 KB)
Read the full article here: People and Business (456.98 KB)
Read the full article here: On The Move (484.38 KB)
Read the full article here: Good Deeds (1.26 MB)

DVM

Read the full article here: Putney wins ‘Best Places to Work in Maine’ award (237.36 KB)
Read the full article here: How Putney Inc. Is Disrupting the Pet Medication Industry (165.21 KB)
Read the full article here: Jean Hoffman Speaks at Bowdoin Breakfast (296.17 KB)
Read the full article here: 42 companies make year’s Best Places to Work in Maine list (151.04 KB)

DVM

Read the full article here: Putney hires 10 new employees in three months (456.31 KB)
Read the full article here: People and Business - New Hires (740.06 KB)
Read the full article here: Chris Lewis Joins Putney as Vice President of Finance (203.17 KB)
Read the full article here: Putney hires seven new team members (532.77 KB)
Read the full article here: Jean Hoffman named 2012 Business Leader of the Year (114.37 KB)